Clinical Trials Browser

Tertiary Lymphoid Structures, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Sarcoma, Colorectal Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer

BESTa

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

Does Genetic Susceptibility for Bleeding Affect Quantitative Faecal Immunochemical Test (qFIT) Results?

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

EMPIRE

TCR1020-CD8 T Cells in KRAS-mutated Cancers

A Pilot Study to Explore the Role of Gut Flora in Colorectal Cancer

Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer

UNTIRE: Cancer-related Fatigue With Digital Treatment

Molecular Effects of Aspirin & Metformin on Colonic Epithelium

Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases

Chromoendoscopy or Narrow Band Imaging (NBI) for Improving Adenoma Detection in Colonoscopy

Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis

Pedaling at a Low-Moderate Intensity During Chemotherapy Administration

Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)

Tucatinib Combined with Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study

Intraperitoneal LSTA1 in CRS-HIPEC

Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer

Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME)

Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer

#CuttingCRC: Barbershop-Based Trial & Colorectal Cancer

Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation

ColErn

Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer

Magnetic Particle-ICG Lymph Node Mapping in Colorectal Cancer

Abscopal Effect for Metastatic Colorectal Cancer

Bohème

Anesthesia, TIVA, Balanced Anesthesia, NK Cell

REFIT-MSS

Technology-Based Cancer Screening Intervention

The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients

Effect of Probiotics Supplementation on the Side Effects of Radiation Therapy Among Colorectal Cancer Patients

PREDICT

MATILDA

Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer

Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery

Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer

A Mobile Aplication for the Promotion of Healthy Lifestyle Habits in Patients With Colorectal Cancer

Endoscopic Optical Imaging for Precision Oncology Treatment Applied to Colorectal Tumours (Elios-Color-on-Specimen)

Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal Cancer

Anti-PD-1 +/- RT for MSI-H Solid Tumors

OMICC

Evaluating the Cologuard Test for Use in Lynch Syndrome

IMMUNOX

mSILSC

Visbiome Effect on Colorectal Anastomosis and Local Recurrence

Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer